Olmesartán/ Hidroclorotiazida Jubilant (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxomil blocks the angiotensin II type 1 (AT1) receptor, preventing the hormone from causing blood‑vessel constriction and aldosterone release. This results in vasodilation and reduced fluid retention, contributing to lower blood pressure.

The specific dose is determined by the prescribing clinician based on the patient’s blood‑pressure readings, kidney function, and overall health. Dosage adjustments are made during treatment to achieve optimal control.

The combination is classified as Pregnancy Category D, indicating potential risk to the fetus, and should be avoided during pregnancy. Safety during breastfeeding has not been established, so use is generally discouraged unless the benefit outweighs the risk.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Olmesartan medoxomil / Hydrochlorothiazide combines an ARB with a thiazide diuretic, offering dual mechanisms that can be more effective than monotherapy. Compared with ACE inhibitors or calcium‑channel blockers, the combination may provide better blood‑pressure reduction in some patients, but individual response varies.

Store the tablets at ambient temperature, preferably below 25 °C. Keep them in the original blister pack or container, protected from moisture and direct sunlight, to maintain stability and potency throughout their shelf life.

The medication is taken orally, usually once daily, with or without food, as directed by the prescribing healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious adverse events include angioedema, severe hypotension, acute kidney injury, and hyperkalemia. Patients should seek immediate medical attention if they experience swelling of the face or throat, dizziness leading to fainting, sudden loss of kidney function, or irregular heart rhythms.

The combination should be avoided in patients with known hypersensitivity to either component, severe renal impairment, hyperkalemia, or in women who are pregnant. Caution is also advised for individuals with a history of angioedema or significant electrolyte disturbances.